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The ability to dynamically regulate, traffic, retain, and recycle proteins within the cell
membrane is fundamental to life and central to the normal function of the heart. In
the cardiomyocyte, these pathways are essential for the regulation of Ca2+, both at
the level of the plasma membrane, but also in local cellular domains. One intracellular
pathway often overlooked in relation to cardiovascular Ca2+ regulation and signaling is
the endosome-based trafficking pathway. Highlighting its importance, this system and
its molecular components are evolutionarily conserved across all metazoans. However,
remarkably little is known of how endosome-based protein trafficking and recycling
functions within mammalian cells systems, especially in the heart. As the endosomal
system acts to regulate the expression and localization of membrane proteins central for
cardiac Ca2+ regulation, understanding the in vivo function of this system in the heart is
critical. This review will focus on endosome-based protein trafficking in the heart in both
health and disease with special emphasis for the role of endocytic regulatory proteins,
C-terminal Eps15 homology domain-containing proteins (EHDs).
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INTRODUCTION
The capacity of a cell to regulate protein expression and local-
ization within the plasma membrane is central to life. Endosome-
based systemsmediate a wide range of cellular processes including
anterograde trafficking of newly formed proteins out of the Golgi
apparatus to their proper locales, internalization of membrane
proteins targeted for recycling or degradation, and nutrient endo-
cytosis. Studying these systems in the intact mammalian cellular
environment has proven difficult, mostly due to the lack of avail-
able tools and model systems. Only within the last 15 years
have we begun teasing out the role of endosome-based protein
trafficking and targeting recycling in vivo. We now know that
endosome-based systems are critical for such cellular processes
as cell motility (Traynor and Kay, 2007), cell division (Boucrot
and Kirchhausen, 2007), cell-cell junction regulation (Palacios
et al., 2002), epithelial polarity (Shivas et al., 2010), and neu-
ronal plasticity (Wang et al., 2008). A growing body of evidence
has implicated endosomal trafficking in the development and reg-
ulation of membrane excitability in neurons (Sun et al., 2014),
pancreatic cells (Manna et al., 2010), and cardiac muscle cells
(McEwen et al., 2007; Kruse et al., 2009; Ishii et al., 2012; Curran
et al., 2014).
In cardiomyocytes, membrane excitability depends on the
proper expression and organization of multiple ion channels,
pumps, exchangers, and transporters within the plasma mem-
brane to regulate intracellular ion signaling pathways. As the
endosomal system acts to regulate the expression and localization
of membrane proteins, the potential exists that this systemmay be
able to modulate excitability in the heart. This regulatory capac-
ity, therefore, makes it an attractive candidate for new therapeutic
intervention in the treatment of arrhythmia and sudden cardiac
death.
ENDOSOMAL TRANSPORT AND CARDIAC EXCITABILITY
Only recently were efforts undertaken to determine the in vivo
role of endosomal pathways in the cardiomyocyte.With the devel-
opment of new tools, years of discovery in surrogate cell systems
may now be translated into mammalian cardiovascular biology.
Years of investigation have demonstrated that C-terminal Eps15
homology domain-containing (EHD) proteins have a functional
role in each segment of endosome-mediated recycling, degra-
dation, and trafficking. EHDs have therefore recently attracted
significant attention as potential therapeutic targets to modulate
endosomal function (Gudmundsson et al., 2010, 2012; Curran
et al., 2014). As cardiac arrhythmia may arise from dysfunctional
expression and organization of multiple membrane proteins lead-
ing to altered Na+ and Ca2+ homeostasis, therapeutically mod-
ulating EHD proteins may prove efficacious in the treatment of
arrhythmia and sudden cardiac death.
EHDs are endocytic regulatory proteins. Discovered in the
last decade, four EHD gene products (EHD1–4) are ubiqui-
tously, albeit differentially-expressed across all tissue types (Pohl
et al., 2000). These proteins are highly conserved throughout
mammalian biology. Indeed, the human and mouse isoforms of
EHD1 share 99.6% sequence similarity (Naslavsky and Caplan,
2005). EHD orthologs in non-mammalian species conserve this
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similarity as well. These data strongly indicate that this family of
proteins plays a similar and central role in metazoan cell biology.
The protein family acquires its name from the presence of an
epidermal growth factor receptor substrate 15 (Eps15) homology
(EH) domain within the C-terminus (Figures 1A,B) (Lee et al.,
2005). By itself, the EH domain is well known to mediate pro-
tein/protein interactions (Salcini et al., 1997; Paoluzi et al., 1998;
Doria et al., 1999; Confalonieri and Di Fiore, 2002; Naslavsky
and Caplan, 2005). This domain typically interacts with proteins
that contain an NPF (asparagine-proline-phenylalanine) motif
(Morgan et al., 2003; Henry et al., 2010; Kieken et al., 2010).
Over 50 proteins containing at least one EH domain have been
identified in the eukaryotic proteome (Polo et al., 2003; Miliaras
and Wendland, 2004). In the C. elegans proteome there are more
than 800 proteins that contain at least one NPF motif, with more
expected in eukaryotes (Pant et al., 2009). Therefore, the potential
for protein/protein interactions in this system is substantial. With
particular importance to this review, proteins containing an EH
domain are often associated with vesicular trafficking, transport,
and sorting (Santolini et al., 1999; Confalonieri and Di Fiore,
2002).
Amongst the identified proteins containing one or more
EH domains, the overwhelming majority of them contain this
domain within the N-terminus. Only a small handful have an
EH domain in the C-terminus (Confalonieri and Di Fiore, 2002).
Notably however, EHD1–4 all express the EH domain within
the C-terminus. The EHD family share high homology with the
C. elegans endocytic regulator protein, receptor-mediated endo-
cytosis 1 (RME-1), which also has a C-terminal EH domain.
RME-1 is known to mediate endosomal trafficking. Therefore,
the distinctive location of the EH domain in mammalian par-
alogs suggested an in vivo functional role of these proteins. When
RME-1 function is disrupted in C. elegans, endosome-based
protein recycling is significantly impaired (Grant et al., 2001).
Critically, Lin et al. found that expressing the human RME-1
ortholog, EHD1, in C. elegans could fully rescue this pheno-
type (Lin et al., 2001). This is unambiguous evidence that not
only are C-terminal EHD proteins directly involved in endo-
somal trafficking, but their function is highly conserved across
metazoans.
One or more EHDs have been demonstrated to play key roles
within every endosome-based protein trafficking compartment.
FIGURE 1 | EHD protein structure and sequence homology. (A) Each
EHD protein is contains an N-terminal region (NT), a dynamin-like domain,
a coiled-coil domain, and a C-terminal EH domain. Typically, the EH
domain mediates protein:protein interactions with EHDs. (B) Ribbon and
space filling models of an EHD protein, based on the known crystal
structure of EHD2 determined by Daumke et al. (2007). (C) The
homology of total amino acid sequence and EH domain identity amongst
the four EHD proteins expressed in mammals (Naslavsky and Caplan,
2011). Note that the overall sequence homology is greater than the
homology shared amongst the EH domains.
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EHDs promote anterograde trafficking from the TGN to the
plasma membrane, along with internalization, recycling, and
degradation pathways (see Naslavsky and Caplan for an expert
review, Naslavsky and Caplan, 2011).While the specificmolecular
roles of EHD1–4 at the level of the vesicle remains poorly defined,
they are hypothesized to serve two simultaneous functions. First,
EHDs act as scaffolding proteins for key molecular players within
the endosome. EHD1–4 have all been demonstrated to asso-
ciate with Rab effector proteins (e.g., Rab11-Fip2, Rabenosyn-5,
MICAL-L1) within membranous vesicular compartments in vivo
(Naslavsky et al., 2004, 2006; George et al., 2007; Sharma et al.,
2008, 2010). EHD proteins may recruit Rab effector proteins to
the vesicle, although this function is not consistently observed
(Naslavsky et al., 2004, 2006). Once present within the vesicle,
the Rab effector can bind to individual Rab proteins that, in turn,
recruit motor proteins such as myosin and dynein (Roland et al.,
2007; Horgan and McCaffrey, 2011; Schafer et al., 2014). Indeed,
recent reports have linked EHD1 with dynein motors (Rahajeng
et al., 2010).
A second, more established role for EHDs is that of membrane
scission. An elegant study by Daumke et al. demonstrated that
when the G domain of an EHD is bound to ATP it will dimer-
ize, forming either hetero- or homo-dimers (Figure 1B). This
creates a membrane binding pocket within the protein complex
(Daumke et al., 2007). These dimers then oligomerize to form
ring-like structures around membranous. Upon ATP hydrolysis,
the membrane binding pocket collapses, destabilizing the asso-
ciated membrane, effectively pinching off the vesicle from the
tubule to facilitate its transport. Indeed, based on this function,
EHD4 is often termed “Pincher” in the literature (Shao et al.,
2002; Smith et al., 2004). Combined with the scaffolding role and
the association with Rab and Rab effectors, these findings nicely
situate EHD proteins to be central players in endosome-based
protein trafficking in vivo.
EHD PROTEINS IN HEART
Nearly all that is known regarding the EHD protein family has
resulted from investigations using surrogate cell systems or model
organisms. The study of endosomal systems in vivo has been
hampered by the lack of appropriate tools. Only recently has
a concerted effort been made to develop the molecular and
biochemical tools and animal models necessary to study these sys-
tems in vivo. For this reason, remarkably little is known not just
about how these systems function in the heart but even about the
identity of the various molecular players involved.
In 2010, Gudmundsson et al. were the first to report that
EHD1–4 were differentially expressed in the four chambers of
the heart (Gudmundsson et al., 2010). EHD1–4 were each shown
to localize within the perinuclear junction and also in discrete
puncta spanning from the nucleus out to the plasma mem-
brane, locales consistent with their role in endosomal trafficking
(Sharma et al., 2009). Further, a direct protein/protein interac-
tion was reported between EHD3 and the cytoskeletal membrane
adapter protein, ankyrin-B (AnkB) (Gudmundsson et al., 2010).
Interestingly, this protein/protein interaction was not mediated
through the EH domain of EHD3 but rather through the coiled-
coil domain. Early in the initial studies of EHD1–4, Naslavsky
and Caplan astutely noted that the overall identity shared by
EHD1–4 was higher than that shared between their individual EH
domains (Figure 1C). They speculated that the conserved func-
tions of EHD1–4 may not rely on the EH domain (Naslavsky and
Caplan, 2005). The surprising finding that EHD3 interacts with
AnkB through the coiled-coil domain supports this speculation
and has potentially broader functional implications for EHD1–4.
Recall, the EH domain directly mediates protein/protein inter-
actions. Moreover, in the case of EHD proteins, the EH domain
has been demonstrated to mediate interactions with Rab effec-
tors and Rab proteins. By interacting with cargo proteins, such
as AnkB, through the coiled-coil region, this would free up the
EH domain to still conduct its business with the motor protein
complex (Rabs/Rab effectors). This places the EHD protein in a
central position within the vesicular complex. It not only binds to,
and recruits the motor complex, it may also simultaneously medi-
ate cargo retention within the endosome. This observation may
prove fundamental to our understanding of how EHD-dependent
endosomal trafficking occurs in vivo.
In the heart, AnkB regulates cardiac calcium and contrac-
tility by controlling the proper targeting and retention of the
Na/Ca exchanger (NCX), Na/K ATPase (NKA), inositol 1,4,5-
trisphosphate receptor, and protein phosphatase 2A (Mohler
et al., 2005; Degrande et al., 2013). Their appropriate subcellular
localization is critical tomaintaining proper cardiac function. The
importance of the relationship between AnkB and these proteins
is highlighted in patients harboring single point variants within
ANK2, encoding for AnkB (Mohler et al., 2003, 2007). These
variants result in a loss-of-function of AnkB and the mislocal-
ization of the associated proteins. Consequently, cardiac function
is severely compromised. These patients suffer from a complex
arrhythmogenic phenotype ranging from ventricular and atrial
fibrillation, sinus node disease, atrioventricular conduction block,
and sudden cardiac death (Mohler et al., 2003).
Given the direct interaction between AnkB and EHD3, it was
hypothesized that silencing EHD3 expressing in the cardiomy-
ocyte would result a mislocalization of AnkB and its binding
partners. Indeed, this was observed. Upon EHD3 silencing by
siRNA, AnkB and NCX localization were disrupted. Both pro-
teins were mislocalized within a perinuclear compartment. These
data suggest that the cell is still synthesizing the protein, but
it was not being trafficked to or retained at the proper subcel-
lular location. In line with this, the NCX-mediated membrane
current (INCX) was significantly downregulated (Gudmundsson
et al., 2010). Interestingly, this same report also demonstrated
that upon EHD3 overexpression in wild type myocytes, INCX
increased. This suggests that endosomal pathways could poten-
tially be targeted to fine tune membrane excitability. This was the
first evidence that EHD3 (or any EHD) played a functional role
in cardiomyocytes to regulate intracellular calcium.
EHD3 MEDIATES MEMBRANE EXCITABILITY AND Ca2+
HOMEOSTASIS IN VIVO
Using newly establishedmousemodels of EHDdeficiency, Curran
et al. provided the first data on the role of EHDs in the intact
heart. EHD3 was found to play critical roles in maintaining
membrane excitability and proper Ca2+ homeostasis in vivo
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(Curran et al., 2014). Hearts from EHD3−/−mice showed dysreg-
ulated AnkB and NCX trafficking and targeting. In isolated adult
ventricular myocytes lacking EHD3, these proteins were mislo-
calized within a perinuclear compartment. Interestingly, in the
EHD3−/− mouse, NCX protein expression was down by only
20%, while INCX was down by approximately 50%. A similar find-
ing was reported for the L-type Ca channel (LTCC). The loss
of EHD3 led to significant mislocalization of the protein. While
overall LTCC protein expression was down less than 20%, the
peak LTCC-mediated membrane current (ICa,L) was down by
approximately 67%. Together, these data suggest that the myocyte
is still synthesizing the NCX and LTCC protein, but the loss of
EHD3 has limited its ability to properly traffic them to their
correct subcellular localizations. Currently, there is no known
interaction between the LTCC and AnkB, implying that the LTCC
is being trafficked in an EHD3-dependent manner that does
not require AnkB. This expands the purview of EHD3 function
beyond that of just AnkB-mediated targeting to include direct or
indirect interactions with other ion channels and transporters.
The LTCC and NCX are intimately involved in EC coupling
and are central players in the maintenance of Ca2+ homeostasis
in the heart (Bers, 2002). The ICa,L triggers further Ca2+ release
from the sarcoplasmic reticulum (SR) through the SR Ca2+
release channel, ryanodine receptor (RyR), a process called Ca2+-
induced Ca2+ release (Bers, 2001). This Ca2+ release induces
muscle contraction. The amount of Ca2+ released ultimately
dictates the strength of contraction. Ca2+ release is primarily dic-
tated by two mechanisms: the size of the Ca2+ trigger and the
size of the SR Ca2+ load. If one of these is downregulated and the
other remains the same, the result will be diminished Ca2+ release
and strength of contraction, or vice versa.
Therefore, one would expect that dysregulation of the LTCC
and NCX observed in the EHD3-deficient mouse would have
ramifications on EC coupling. Indeed, in ventricular myocytes
isolated from EHD3−/− mice, the average SR Ca2+ load was
increased approximately 40%. This is likely a compensatory
response to the downregulation of the ICa,L and INCX . The loss
of these two membrane currents would favor Ca2+ retention
in the cell, thereby increasing the SR Ca2+ concentration (Bers
et al., 1996; McCall et al., 1998). This increase in SR Ca2+
concentration would have the effect of sensitizing the RyR to
Ca2+, thereby promoting increased Ca2+ release in the face of
downregulated Ca2+ trigger (Bassani et al., 1995). In this fash-
ion, contractility was maintained in the EHD3-deficient heart,
similar to observations in mice deficient in NCX (Pott et al.,
2005).
EHD3-dependent trafficking mechanisms will likely include
other ion channels and transporters. The action potential dura-
tion (APD) of EHD3−/− myocytes was approximately 60%
shorter compared to WT (Curran et al., 2014). While the NCX
and the LTCC both play roles in mediating the APD, even if
combined the amount of membrane current lost due to dysreg-
ulation of these proteins in the EHD3−/− heart cannot account
for such a drastic shortening of the APD. This strongly sug-
gests that EHD3 mediates the trafficking of other ion channels or
regulatory proteins pertinent to developing the action potential.
Future investigations should aim at uncovering the relationship
between EHD3 and these other proteins, particularly the family
of potassium channels.
HEART RHYTHM, AUTOMATICITY, AND CONDUCTION
DEFECTS IN EHD3-DEFICIENT HEARTS
Beyond their roles in Ca2+ homeostasis and contraction in the
heart, the NCX and LTCC also mediate automaticity and action
potential conduction (Lyashkov et al., 2007; Monfredi et al.,
2013a,b). In particular, they play vital roles within the “Ca2+
clock” machinery of the sinoatrial node (SAN) where they facil-
itate spontaneous membrane depolarization and the origin of
the cardiac action potential (Maltsev and Lakatta, 2009; Lakatta
et al., 2010). Further, LTCC function is required for the proper
conduction of the action potential from the atria to the ven-
tricle through the atrioventricular node (Zhang et al., 2011).
Disruption of NCX and LTCC function would be expected to
have considerable consequences on cardiac rhythm and action
potential conduction.
EHD3 is expressed in the SAN (Curran et al., 2014). Given the
functional role of EHD3 in trafficking and targeting the NCX and
LTCC, dysregulation of cardiac automaticity in these mice would
be predicted. Indeed, significant increases in heart rate variabil-
ity and SAN pause were observed in the EHD3-deficient mouse.
Furthermore, incidences of antrioventricular (AV) node conduc-
tion block were routinely detected. These observations strongly
suggest that EHD3-dependent endosomal trafficking is required
for proper cardiac automaticity and conduction. While no data
yet exists investigating EHD3 function directly in SAN or AV node
cells, it is intriguing to envision that NCX and LTCC trafficking
and function are dysregulated in a similar manner as is observed
in the ventricle. It is likely that the rhythm and conduction dis-
turbances observed in EHD3-deficient mice are directly related to
dysregulated NCX and LTCC function.
EHD PROTEINS AND HEART FAILURE
In nearly all forms of heart failure, a common observation is
the increased expression and function of NCX within the mem-
brane. While initially a compensatory mechanism, this increased
NCX expression eventually becomes maladaptive and supplies
an arrhythmogenic substrate (Pogwizd et al., 1992, 1999). This
membrane remodeling is not limited to human, as increased NCX
expression is commonly observed in animal models of heart fail-
ure (Baartscheer et al., 2003; Wei et al., 2007; Wang et al., 2009;
Kohlhaas and Maack, 2010). This suggests that this response is
evolutionarily conserved. Development of a specific pharmaco-
logical inhibitor of the NCX aimed at attenuating arrhythmogen-
esis is an area of active research. However, success in this endeavor
has been elusive.
Recent data has indicated that EHD3 is also increased in
human heart failure and in all animal models of heart failure yet
examined (Gudmundsson et al., 2012). This observation coupled
with what is now known about EHD3-dependent NCX trafficking
in the heart provides a plausible molecular mechanism by which
the heart mediates NCX expression in response to heart failure.
These data imply that EHD3 may be involved in the electrical
remodeling of the plasma membrane associated with heart fail-
ure. If this is the case, EHD-dependent endosomal trafficking may
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provide a new approach to developing novel therapeutics against
arrhythmia. A significant amount of work must be undertaken
to more fully describe the function and molecular machinery of
these endosomal trafficking pathways in the heart.
CONCLUSION AND FUTURE DIRECTIONS
A deeper understanding of endosomal trafficking may offer new
avenues for therapies against arrhythmia and heart failure. The
vast majority of arrhythmias are associated with ion channel or
transporter dysfunction. For this reason, the field has pushed
for ion channel-based therapeutic strategies. While the logic
behind this approach is sound, it has unfortunately been met
with limited success. In fact, as the CAST-II trial revealed, when
anti-arrhythmic drugs were administered to patients, the rate
of arrhythmogenesis in these patients increased (Greene et al.,
1992). A secondary approach is therefore needed. Targeting the
endosomal trafficking of specific ion channels and transporters
may provide that approach.
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